Clinical trial
A Phase II Trial of Topical Halofuginone in Patients With HIV Related Kaposi's Sarcoma
NCT00064142 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II Trial of Topical Halofuginone in Patients With HIV Related Kaposi's Sarcoma
- Lead sponsor
- National Cancer Institute (NCI)
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- May 31, 2003
- Completion date
- Not reported
- Enrollment
- 30 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
aids-related kaposi sarcoma, recurrent kaposi sarcoma